1-Hydroxymethyl-LSD
| Clinical data | |
|---|---|
| Other names | OML-632; OML632; 1-Hydroxymethyllysergic acid diethylamide; 1-Hydroxymethyl-d-lysergic acid diethylamide; 1-Oxy-methyl-LSD; 1-Oxymethyl-LSD; Oxymethyl-LSD |
| Routes of administration | Oral |
| Drug class | Serotonin receptor modulator; Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| Chemical and physical data | |
| Formula | C21H27N3O2 |
| Molar mass | 353.466 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
OML-632, also known as 1-hydroxymethyllysergic acid diethylamide (1-hydroxymethyl-LSD), is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).
It has about 66% of the hallucinogenic potency of LSD in humans (which is stated as active at 50–100 μg) and about 59% of the antiserotonergic activity of LSD in the isolated rat uterus in vitro. However, OML-632 may simply act as a prodrug of LSD.
OML-632 was first described in the scientific literature by 1957. The compound has been mistakenly referred to as "1-methoxy-LSD" or "1-MeO-LSD" in some publications.